Liraglutide provided cardiovascular benefit to oldest patients, post hoc analysis finds | ACP Diabetes Monthly
Researchers analyzed the industry-funded LEADER trial, focusing on the oldest patients who were randomized to liraglutide or placebo.
The updated guideline from the World Health Organization (WHO) included five recommendations, some of which differed from ACP's most recent diabetes guideline.
Ten studies from 2013 with potential to change endocrinology practice were summarized in Annals of Internal Medicine's annual Update in Endocrinology, published in the June 3 issue.
Whether to screen a patient for type 2 diabetes is the focus of a Beyond the Guidelines feature in the Oct. 4 Annals of Internal Medicine.
The synopsis by diabetes experts was written specifically for primary care physicians and summarized the ADA Standards of Medical Care in Diabetes into 8 areas of importance.
A new video from the Consult Guys, Geno J. Merli, MD, FACP, and Howard H. Weitz, MD, FACP, addresses inpatient glucose control. “Hyperglycemia: Am I a Control Freak?” was released online Dec. 17, 2013.
Task force recommends combined diet and physical activity effort for diabetes prevention | ACP Diabetes Monthly
The Community Preventive Services Task Force recommended the use of combined diet and physical activity promotion programs for people at increased risk for type 2 diabetes in a recent clinical guideline.
Of the many recommendations in the American Diabetes Association's (ADA) updated Standards of Medical Care in Diabetes, 3 were chosen as particularly important for nonendocrinologists by the authors of a recent commentary in Annals of Internal
Very few patients with prediabetes are prescribed metformin, according to a recent study of working-age adults.
Patients who were diagnosed with diabetes before age 40 years had significantly higher risk of hospitalization for renal, cardiovascular, and infectious causes, but this was reduced with good risk factor control.